BioPartner UK

We are an independent, accredited trade organisation that supports UK international trade.

[Bionow @Bionow]

#Bionow partner @BioPartner negotiates entry fee #discounts for UK companies attending many major international #BiopharmaEvents. Bionow Members can claim discounts at the BioPartner Alliance Member rate, as well as join a BioPartner UK Delegation.

https://t.co/wDin1Dvtc1

[BioPartner UK @BioPartner]

BIO-Europe tickets for almost half price? Yes please! 💸 👏

Register through BioPartner UK and save up to €2370 (thats 43%!)

Find out more and register here: https://t.co/M2nQRe0gdI

#BIOEurope #Cologne #Partnering #LifeScience #Conference #Event

[Scendea @scendea]

Scendea are hiring! Are you a skilled and motivated individual seeking a challenging and rewarding career? Discover our open vacancies and apply today: https://t.co/ZCPiJjYCFC
-
#drugdevelopment #regulatoryaffairsroles #hiring #lifeatscendea

[BioPartner UK @BioPartner]

Thinking of attending Biospain? Why not get the most out of your experience by joining the UK Delegation?🇬🇧🇪🇸 Sign up here https://t.co/qQnm2zSGk5

Don’t miss your opportunity to be a part of the UK Guest Country Delegation at #BioSpain2026! Get your pass today.

[Scendea @scendea]

We are proud to share that Scendea is now a certified B Corporation™! Watch our journey below and learn more about what being a B Corp means to Scendea.
-
#BCorp #BCorpCertified #BusinessAsAForceForGood #ESG #Sustainability #LifeAtScendea

[BioPartner UK @BioPartner]

🌍 If you’re a UK business selling or wanting to sell goods or services outside the UK, BioPartner UK has a dedicated export support page to help increase your international opportunities https://t.co/9noPUgWOgE

#BioPartner #ExportSupport #InternationalTrade #ATO

[Bionow @Bionow]

EXHIBITORS: Boost your profile at the #Bionow #Neuroscience conference on 9 July, with #exhibitor packages starting at just £450, including 2 delegate passes. Get your company in front of academics, clinicians and industry leaders.

Find out more:

https://t.co/wSG43xW8e4

[Scendea @scendea]

The EMA has updated a series of assessment timetable documents relating to initial marketing authorisation applications. Get in touch to discuss how the updated EMA timetables may affect your strategy: https://t.co/ijtMXc2PCT

[Poolbeg Pharma @PoolbegPharma]

Our Chief Executive Officer Jeremy Skillington & Chief Financial Officer Ian O'Connell will be attending @IAmBiotech Bio International Convention, one of the world’s leading events for the biotechnology and life sciences industry.

📍San Diego, US
🗓️22-25 June 2026

With interim data from the POLB 001 TOPICAL trial expected this summer, alongside the recent Canadian patent grant, momentum continues to build across the programme. The team looks forward to engaging with potential partners at BIO to discuss the clinical progress, our expanding IP portfolio, and broader commercial opportunity ahead.

If you’re attending BIO 2026, connect with our team via the BIOpartnering platform.

Learn more:
https://t.co/kr5hellIhj

#POLB #BIO2026 #Biotech #LifeSciences #HealthcareInnovation #Biotechnology #Networking #Innovation #BIOInternational

[EFB Biotechnology @EFBiotechnology]

🙏 A big thank you to the #ECB2026 sponsors & exhibitors!

Your support helps young scientists attend the congress through reduced registration fees 🧬🌍

Interested in becoming a sponsor or exhibitor?
🔗 https://t.co/HvS9A6Sz9y
#Biotechnology #LifeSciences

[BioPartner UK @BioPartner]

Make the most of #BIO26's advanced rates with an additional $405 off when you register through @BioPartner

Register and save today! https://t.co/bepOcC9IjT

T&Cs apply.

[Bionow @Bionow]

LAST CHANCE TO BOOK: 💪 Empowering #WomenInBiotech 💪 is at BioCity Glasgow THIS THU so join #Bionow for this inclusive and FREE (for Members) #networking event sharing women's success stories from #academia, #biotech and #LifeSciences. ALL welcome!

https://t.co/1q1x2G1ftU

[Poolbeg Pharma @PoolbegPharma]

To enhance our expertise in the Cytokine Release Syndrome space we have appointed Dr Adrian Kilcoyne to our Scientific Advisory Board.

Dr Kilcoyne bring over 20 years of clinical expertise with strategic drug development leadership, focusing on innovative therapies that address unmet medical needs in oncology and immunology and, in particular, brings deep knowledge of haematological malignancies, T-cell therapies and Cytokine Release Syndrome.

Adrian’s wealth of experience will provide further support to our established team of experts as we progress POLB 001 through the TOPICAL trial with the ultimate aim of transforming cancer care for patients and healthcare systems.

Learn more about Dr Kilcoyne’s experience and read the full announcement here:
https://t.co/KHmdSESktU

#POLB #SAB #ScientificAdvisory #BoardMember #AIM #Cancer #Oncology #ScientificExpert

[Bionow @Bionow]

And that was the 2025 #BionowAwards! Thank you to all our nominees, attendees and sponsors for making the evening truly special. Now head over to our event summary to check out the full list of award winners!

https://t.co/98Plm6PR9P

#LifeSciences #Networking #CelebratingSuccess

[National Institute for Health and Care Research @NIHRresearch]

Develop your leadership and management skills with our 17 free online modules. They share the latest leadership tools to enable you to reflect on and practise new approaches.

Login or register on NIHR Learn to find out more:
https://t.co/jyhnh0CLyd

[Scendea @scendea]

The @US_FDA has published a paper on a plausible mechanism pathway, a #regulatory framework to accelerate approval of bespoke, #patient-specific #therapies when traditional trials are not feasible.
-
For more information on this guidance, get in touch: https://t.co/ijtMXc2PCT

[BioPartner UK @BioPartner]

The @BioPartner News Roundup is out, featuring the #latestnews from our members, @Stablepharma1 and @_REPROCELL. We want to shout out our event partner @MedTechWorld.

Catch the latest on our website – https://
https://t.co/EGrtNvCRp3

#Lifesciences #NewsUpdate

[Scendea @scendea]

The @US_FDA has published a guidance titled, “Scientific Considerations in Demonstrating #Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies (CES)”.
-
#guidanceupdate #scientificconsiderations #USregulatorysupport

[Poolbeg Pharma @PoolbegPharma]

Video clips & a post-event update from CEO Jeremy Skillington at this weeks' EBD Group's BIO-Europe in Vienna!

The team were delighted to join so many industry colleagues to explore the future of biotech and pharma.

A big thank you to everyone who took the time to connect with our team. We look forward to continuing the momentum and driving meaningful outcomes in the life sciences.

#POLB #BIOEUROPE #Vienna #Conference #Pharma #Biotech

[BioPartner UK @BioPartner]

What an incredible week at #BIOEurope!
A huge thank you to everyone who stopped by the #UKPavilion, your energy and our conversations made it a truly productive outing.

BioPartner UK is proud to have showcased the best of #UKLifesciences with our amazing #UKDelegation. 🇬🇧